The trademark application LYVFIRLA was filed by Intercept Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 3, 2020, and it was registered by office on February 10, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 4, 2021. Appointment and Replacement of representative of the trademark registration was recorded on February 15, 2021.